FY2023 EPS Estimates for NovoCure Limited (NASDAQ:NVCR) Reduced by Leerink Partnrs
NovoCure Limited (NASDAQ:NVCR – Free Report) – Leerink Partnrs decreased their FY2023 earnings estimates for shares of NovoCure in a report issued on Tuesday, November 28th. Leerink Partnrs analyst J. Chang now forecasts that the medical equipment provider will earn ($2.07) per share for the year, down from their prior estimate of ($2.00). The consensus […]